06 Nov 2026
byProf. Christos Chouaid, Department of Pneumology and Thoracic Oncology , Intercommunal Hospital of Creteil, France
Not all patients with advanced non-small-cell lung cancer (NSCLC) are eligible for platinum-based chemotherapy. Oral vinorelbine may be a valuable treatment option for frail and older patients in both first- and subsequent-line settings due to its manageable safety profile.
